• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

短链脂肪酸在肠道屏障功能、炎症、氧化应激和结肠癌变中的作用。

The role of short-chain fatty acids in intestinal barrier function, inflammation, oxidative stress, and colonic carcinogenesis.

机构信息

Department of Radiation Oncology, The First Hospital of Jilin University, Changchun 130021, China; Key Laboratory of Pathobiology, Ministry of Education, Jilin University, Changchun 130021, China; Jilin Provincial Key Laboratory of Radiation Oncology & Therapy, The First Hospital of Jilin University, Changchun 130021, China.

Department of Orthopedic, The Second Hospital of Jilin University, Changchun, 130041, China.

出版信息

Pharmacol Res. 2021 Mar;165:105420. doi: 10.1016/j.phrs.2021.105420. Epub 2021 Jan 9.

DOI:10.1016/j.phrs.2021.105420
PMID:33434620
Abstract

Short-chain fatty acids (SCFAs), mainly including acetate, propionate, and butyrate, are metabolites produced during the bacterial fermentation of dietary fiber in the intestinal tract. They are believed to be essential factors affecting host health. Most in vitro and ex vivo studies have shown that SCFAs affect the regulation of inflammation, carcinogenesis, intestinal barrier function, and oxidative stress, but convincing evidence in humans is still lacking. Two major SCFA signaling mechanisms have been identified: promotion of histone acetylation and activation of G-protein-coupled receptors. In this review, we introduce the production and metabolic characteristics of SCFAs, summarize the potential effects of SCFAs on the four aspects mentioned above and the possible mechanisms. SCFAs have been reported to exert a wide spectrum of positive effects and have a high potential for therapeutic use in human-related diseases.

摘要

短链脂肪酸(SCFAs)主要包括乙酸盐、丙酸盐和丁酸盐,是肠道中膳食纤维细菌发酵产生的代谢产物。它们被认为是影响宿主健康的重要因素。大多数体外和离体研究表明,SCFAs 影响炎症、癌变、肠道屏障功能和氧化应激的调节,但在人类中仍缺乏令人信服的证据。已经确定了两种主要的 SCFA 信号机制:促进组蛋白乙酰化和激活 G 蛋白偶联受体。在这篇综述中,我们介绍了 SCFAs 的产生和代谢特征,总结了 SCFAs 对上述四个方面的潜在影响及其可能的机制。据报道,SCFAs 具有广泛的积极作用,在人类相关疾病的治疗中有很高的应用潜力。

相似文献

1
The role of short-chain fatty acids in intestinal barrier function, inflammation, oxidative stress, and colonic carcinogenesis.短链脂肪酸在肠道屏障功能、炎症、氧化应激和结肠癌变中的作用。
Pharmacol Res. 2021 Mar;165:105420. doi: 10.1016/j.phrs.2021.105420. Epub 2021 Jan 9.
2
Role of short-chain fatty acids in colonic inflammation, carcinogenesis, and mucosal protection and healing.短链脂肪酸在结肠炎症、致癌作用以及黏膜保护与愈合中的作用。
Nutr Rev. 2017 Apr 1;75(4):286-305. doi: 10.1093/nutrit/nuw067.
3
Short-chain free-fatty acid G protein-coupled receptors in colon cancer.结直肠癌中的短链游离脂肪酸 G 蛋白偶联受体。
Biochem Pharmacol. 2021 Apr;186:114483. doi: 10.1016/j.bcp.2021.114483. Epub 2021 Feb 23.
4
Short-chain fatty acids in the human colon: relation to gastrointestinal health and disease.人体结肠中的短链脂肪酸:与胃肠道健康和疾病的关系。
Scand J Gastroenterol Suppl. 1996;216:132-48. doi: 10.3109/00365529609094568.
5
Secondary Bile Acids and Short Chain Fatty Acids in the Colon: A Focus on Colonic Microbiome, Cell Proliferation, Inflammation, and Cancer.次级胆酸和结肠中的短链脂肪酸:关注结肠微生物组、细胞增殖、炎症和癌症。
Int J Mol Sci. 2019 Mar 11;20(5):1214. doi: 10.3390/ijms20051214.
6
Regulation of inflammation by short chain fatty acids.短链脂肪酸对炎症的调节作用。
Nutrients. 2011 Oct;3(10):858-76. doi: 10.3390/nu3100858. Epub 2011 Oct 14.
7
Benefits of short-chain fatty acids and their receptors in inflammation and carcinogenesis.短链脂肪酸及其受体在炎症和致癌作用中的益处。
Pharmacol Ther. 2016 Aug;164:144-51. doi: 10.1016/j.pharmthera.2016.04.007. Epub 2016 Apr 23.
8
Systemic availability and metabolism of colonic-derived short-chain fatty acids in healthy subjects: a stable isotope study.健康受试者中结肠源性短链脂肪酸的全身可用性和代谢:一项稳定同位素研究。
J Physiol. 2017 Jan 15;595(2):541-555. doi: 10.1113/JP272613. Epub 2016 Sep 18.
9
Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases.短链脂肪酸(SCFAs)介导的肠道上皮和免疫调节及其对炎症性肠病的相关性。
Front Immunol. 2019 Mar 11;10:277. doi: 10.3389/fimmu.2019.00277. eCollection 2019.
10
Short-chain fatty acids augment rat duodenal mucosal barrier function.短链脂肪酸增强大鼠十二指肠黏膜屏障功能。
Exp Physiol. 2017 Jul 1;102(7):791-803. doi: 10.1113/EP086110. Epub 2017 May 25.

引用本文的文献

1
Fecal microbiomes from healthy adult consumers of fruits and vegetables exhibit fiber- and donor-specific fermentation: "5 a day" is not enough.健康的成年果蔬食用者的粪便微生物群表现出纤维和供体特异性发酵:“一天五份”是不够的。
Food Funct. 2025 Sep 8. doi: 10.1039/d5fo00947b.
2
Dietary microbes and functional dyspepsia: modulating the gut microecology for therapeutic benefit.饮食中的微生物与功能性消化不良:调节肠道微生态以获得治疗益处。
Front Nutr. 2025 Aug 19;12:1625987. doi: 10.3389/fnut.2025.1625987. eCollection 2025.
3
Commentary: Synergistic treatment of sodium propionate and Sishen Pill for diarrhea mice with kidney-yang deficiency syndrome.
述评:丙酸钠与四神丸协同治疗肾阳虚证腹泻小鼠
Front Cell Infect Microbiol. 2025 Aug 13;15:1646463. doi: 10.3389/fcimb.2025.1646463. eCollection 2025.
4
Efficacy of spp. Interventions to Modulate Mood Symptoms: A Scoping Review of Clinical Trials.用于调节情绪症状的** spp.** 干预措施的疗效:一项临床试验的范围综述
Int J Mol Sci. 2025 Aug 21;26(16):8099. doi: 10.3390/ijms26168099.
5
A Low Dose of Berberine Is Metabolized in Weaned Piglets Without Major Changes to Gut Morphology or Gut Microbiota.低剂量小檗碱在断奶仔猪体内代谢,对肠道形态或肠道微生物群无重大影响。
Animals (Basel). 2025 Aug 21;15(16):2450. doi: 10.3390/ani15162450.
6
Effect of Dietary Difructose Anhydride III Supplementation on the Metabolic Profile of Japanese Black Breeding Herds with Low-Level Chronic Exposure to Zearalenone in the Dietary Feed.日粮中添加二果糖酐III对日粮中低水平长期暴露于玉米赤霉烯酮的日本黑种猪代谢特征的影响。
Toxins (Basel). 2025 Aug 14;17(8):409. doi: 10.3390/toxins17080409.
7
Mycotoxin-Caused Intestinal Toxicity: Underlying Molecular Mechanisms and Further Directions.霉菌毒素引起的肠道毒性:潜在分子机制及未来方向
Toxics. 2025 Jul 26;13(8):625. doi: 10.3390/toxics13080625.
8
Gut microbiota and tuberculosis.肠道微生物群与结核病
Imeta. 2025 Jun 22;4(4):e70054. doi: 10.1002/imt2.70054. eCollection 2025 Aug.
9
Probiotics in inflammatory bowel diseases: emphasis on mechanisms and clinical application.炎症性肠病中的益生菌:着重于作用机制及临床应用
Front Med (Lausanne). 2025 Aug 1;12:1620079. doi: 10.3389/fmed.2025.1620079. eCollection 2025.
10
Decoding the impact of gut microbiota on heart failure.解读肠道微生物群对心力衰竭的影响。
Genes Dis. 2025 Mar 6;12(6):101592. doi: 10.1016/j.gendis.2025.101592. eCollection 2025 Nov.